@ARTICLE{
author={Kao SCH,Reck M,Liu SV,Dziadziuszko R,Hochmair MJ,Huemer F,Gilberto de Castro J,Bernabe Caro R,Kim SH,Kowalski DM,Andric Zoran G,Oancea M,Kaul M,Li H,Danner B,Lee MC,Nabet BY,Sugawara S},
year={2024},
title={Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo)},
journal={ANNALS OF ONCOLOGY},
volume={35},
number={},
pages={S1638-S1638},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Dziadziuszko R,...,Andric Zoran G,...,(broj koautora 20)},
year={2021},
title={Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C},
journal={ANNALS OF ONCOLOGY},
volume={32},
number={},
pages={S950-S951},
document_type={Meeting Abstract},
}